arteritis


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

ar·te·ri·tis

 (är′tə-rī′tĭs)
n.
Inflammation of an artery or arteries.

arteritis

(ˌɑːtəˈraɪtɪs)
n
(Pathology) pathol inflammation of an artery

ar•te•ri•tis

(ˌɑr təˈraɪ tɪs)

n.
inflammation of an artery.
[1830–40]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.arteritis - inflammation of an artery
periarteritis - inflammation of the outer coat of an artery
polyarteritis - inflammation of several arteries
pulseless disease, Takayasu's arteritis - disorder characterized by the absence of a pulse in both arms and in the carotid arteries
temporal arteritis - inflammation of the temporal arteries; characterized by headaches and difficulty chewing and (sometimes) visual impairment
inflammation, redness, rubor - a response of body tissues to injury or irritation; characterized by pain and swelling and redness and heat
Translations

ar·te·ri·tis

n. arteritis, infl. de una arteria.

arteritis

n arteritis f; giant cell — arteritis de células gigantes; Takayasu’s — arteritis de Takayasu; temporal — arteritis temporal
References in periodicals archive ?
It is also being evaluated as a potential treatment for ankylosing spondylitis, and the company plans to begin registration-enabling studies in atopic dermatitis, ulcerative colitis, and giant cell arteritis this year.
The cost watchdog's ruling means it is unlikely that patients with giant cell arteritis will have access to the treatment any time soon.
Giant cell arteritis (GCA) is the most common vasculitis of the elderly, primarily affecting individuals over 50 years of age.
Takayasu's aortoarteritis (TA) is a chronic, progressive, idiopathic, occlusive arteritis of the aorta and aortic arch branches.
Giant cell arteritis (GCA) is an inflammatory lesion of the large- and medium-sized arteries, which usually involves the cranial arteries of older women.
It is recommended for temporal arteritis (inflamed arteries), varicose veins, lumbago, sciatica, rheumatism, intermittent claudication (lameness in the legs due to poor blood supply), restlessness in children, sleeplessness, whooping cough, chronic bronchitis and parasthesia (chronic pins and needles).
THE FOOD AND DRUG Administration has approved subcutaneous tocilizumab (Actemra) for the treatment of giant cell arteritis.
Todays FDA decision means people living with giant cell arteritis will, for the first time, have an FDA-approved treatment option for this debilitating disease, said Sandra Horning, MD, Chief Medical Officer and Head of Global Product Development.
Takayasu arteritis (TA) is a medium and large vessel vasculitis of unknown etiology characterized by chronic granulomatous inflammation of the vessel wall leading to thickening, stenosis, dilatation, and/or aneurysm of the affected vessel.
There are also about 11,000 people with the more serious condition giant cell arteritis, a condition in which medium and large arteries, usually in the head and neck, become inflamed.